印度癌症治疗财务毒性：缩小癌症护理差距 Table_1（DOCX）

数据集获取（Figshare）

• 源站标题：Table_1_Financial toxicity of cancer treatment in India: towards closing the cancer care gap.DOCX
• DOI：10.3389/fpubh.2023.1065737.s001
• 发布日期：2023-06-19
• 文件数：1 个
• 文件总体积：489.72 KB
• 源站页面：https://frontiersin.figshare.com/articles/dataset/Table_1_Financial_toxicity_of_cancer_treatment_in_India_towards_closing_the_cancer_care_gap_DOCX/23540985

命令行下载

curl -L -o "Table_1_Financial toxicity of cancer treatment in India: towards closing the cancer care gap.DOCX" "https://ndownloader.figshare.com/files/41289540"

文件清单

• Table_1_Financial toxicity of cancer treatment in India: towards closing the cancer care gap.DOCX（489.72 KB）

文件总体积 489.72 KB（源站 API 实测）。

数据说明

BackgroundThe rising economic burden of cancer on patients is an important determinant of access to treatment initiation and adherence in India. Several publicly financed health insurance (PFHI) schemes have been launched in India, with treatment for cancer as an explicit inclusion in the health benefit packages (HBPs). Although, financial toxicity is widely acknowledged to be a potential consequence of costly cancer treatment, little is known about its prevalence and determinants among the Indian population. There is a need to determine the optimal strategy for clinicians and cancer care centers to address the issue of high costs of care in order to minimize the financial toxicity, promote access to high value care and reduce health disparities.
MethodsA total of 12,148 cancer patients were recruited at seven purposively selected cancer centres in India, to assess the out-of-pocket expenditure (OOPE) and financial toxicity among cancer patients. Mean OOPE incurred for outpatient treatment and hospitalization, was estimated by cancer site, stage, type of treatment and socio-demographic characteristics. Economic impact of cancer care on household financial risk protection was assessed using standard indicators of catastrophic health expenditures (CHE) and impoverishment, along with the determinants using logistic regression.
ResultsMean direct OOPE per outpatient consultation and per episode of hospitalization was estimated as ₹8,053 (US$ 101) and ₹39,085 (US$ 492) respectively. Per patient annual direct OOPE incurred on cancer treatment was estimated as ₹331,177 (US$ 4,171). Diagnostics (36.4%) and medicines (45%) are major contributors of OOPE for outpatient treatment and hospitalization, respectively. The overall prevalence of CHE and impoverishment was higher among patients seeking outpatient treatment (80.4% and 67%, respectively) than hospitalization (29.8% and 17.2%, respectively). The odds of incurring CHE was 7.4 times higher among poorer patients [Adjusted Odds Ratio (AOR): 7.414] than richest. Enrolment in PM-JAY (CHE AOR = 0.426, and impoverishment AOR = 0.395) or a state sponsored scheme (CHE AOR = 0.304 and impoverishment AOR = 0.371) resulted in a

许可

CC BY 4.0

引用

学术使用请引用 DOI 10.3389/fpubh.2023.1065737.s001（source: https://frontiersin.figshare.com/articles/dataset/Table_1_Financial_toxicity_of_cancer_treatment_in_India_towards_closing_the_cancer_care_gap_DOCX/23540985）。